Ossigeno Medicair (Oxygen)

Oxygen, the active ingredient in Ossigeno Medicair, is a medical gas presented as a inhalation therapy for respiratory support use. It provides supplemental oxygen to patients with compromised breathing or low blood oxygen levels. GNH USA supplies Ossigeno Medicair as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Ossigeno Medicair as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Ossigeno Medicair is used in respiratory support and oxygen therapy pathways: - Acute hypoxemia: Improves oxygen saturation and tissue oxygen delivery. - Chronic obstructive pulmonary disease (COPD): Helps alleviate dyspnea and maintain adequate oxygen levels. - Peri‑operating period: Supports oxygenation during and after surgical procedures. - High‑altitude exposure: Assists  the body  to  acclimatize  by  supplying  supplemental  oxygen  at  lower  ambient  pressures. - Pulmonary embol            ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​